Brief: Edap Announces Completion Of Enrollment In Phase 3 Study
01/02/2024 13:06
Feb 1 (Reuters) - Edap Tms SA EDAP.O :
* EDAP ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 3 STUDY
EVALUATING FOCAL ONE HIFU THERAPY FOR THE TREATMENT OF DEEP
INFILTRATING RECTAL ENDOMETRIOSIS
* EDAP TMS SA: STUDY RESULTS EXPECTED IN SECOND HALF OF 2024
Source text for Eikon: ID:nGNX2zVrDr
Further company coverage: EDAP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edap Tms SA
See all newsEdap Tms SA reports results for the quarter ended June 30 - Earnings Summary
FocalTherics slides after $40 million share sale
Brief: Focaltherics™ Announces Pricing Of Public Offering Of American Depositary Shares
Brief: Focaltherics™ Announces Proposed Public Offering Of American Depositary Shares
Edap Tms SA expected to post a loss of 20 cents a share - Earnings Preview